This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Masahiro Takamura: Innovator in Pharmaceutical Chemistry
Introduction
Masahiro Takamura is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to pharmaceutical chemistry, particularly in the development of compounds aimed at treating schizophrenia and other central neurological diseases.
Latest Patents
Takamura holds a patent for an invention titled "N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof." This innovative compound demonstrates high effectiveness against positive symptoms, negative symptoms, and cognitive dysfunction associated with schizophrenia. It also aims to reduce the risks of conventional side effects while providing remarkable effects for other cognitive dysfunction-related neurological diseases.
Career Highlights
Takamura is affiliated with Dainippon Sumitomo Pharma Co., Ltd., where he has made significant strides in pharmaceutical research and development. His work focuses on creating effective treatments that enhance the quality of life for individuals suffering from mental health disorders.
Collaborations
Throughout his career, Takamura has collaborated with notable colleagues, including Megumi Maruyama and Naoya Kinomura. These partnerships have contributed to the advancement of innovative solutions in the pharmaceutical field.
Conclusion
Masahiro Takamura's work exemplifies the impact of innovation in the pharmaceutical industry. His dedication to developing effective treatments for schizophrenia and related conditions highlights the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile